Image via DeviceTalks
Last updated
Abbott: Product Launch
Abbott is presenting at DeviceTalks Minnesota 2026 conference (May 4) with senior executive speaker Lisa Earnhardt, indicating active participation in medical device sector events and likely product/innovation showcase.
Source: DeviceTalks
The leadership read
Product momentum tends to widen medtech product and commercial leadership bench strength.
Market context: The wider read — a Talent Market Index of 105.9 (Hot), down 2.3 month-on-month — shows Americas signal flow rising (+2.4pts).
Abbott: 2 signals in the last 90 days — above the MedTech median of 1 across 20 tracked companies; 0.2% of MitchelLake's Americas signal flow; 5 tracked across 83 days.
MitchelLake in this thematic
Also at Abbott →
More signals across MedTech
Product Launch · Americas
Medtronic →Medtronic received FDA 510(k) clearance in June 2026 for its Nellcor pulse oximetry system with Nell-EQ intelligent processor. Product designed to improve oxygen saturation and pulse rate monitoring accuracy across diverse skin tones and care settings, aligned with new ISO 80601-2-61:2026 standards.
Product Launch · Americas
Illumina →Illumina launched fireflyGO automation platform in partnership with SPT Labtech, designed to accelerate targeted oncology research
Product Launch · Americas
Caris Life Sciences →Caris Life Sciences submitted application to NY State Department of Health for Caris Assure Blood-Based Testing Authorization, expanding their precision medicine offerings
Partnership · Americas
Sectra →Sectra deployed its Sectra One Cloud fully managed SaaS cloud enterprise imaging solution to Hennick Humber Hospital in Canada to improve radiology workflows and patient diagnostics.
Ma Activity · Americas
Analog Devices →Analog Devices completed acquisition of Empower Semiconductor to strengthen its position as a power partner across the AI ecosystem
Restructuring · Americas
Insulet Corporation →Manufacturing issues at Insulet's Acton facility led to medical device corrections affecting millions of insulin pump pods. SEC filings had previously claimed quality assurance inspections at various manufacturing steps, creating disclosure gap and triggering investor litigation.
Intelligence powered by Autonodal ↗